In Vivo Pharmacological Characterisation of Bilastine, a Potent and Selective Histamine H 1 Receptor Antagonist

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustín   Orjales Aurelio  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

Combined histamine H 1 /H 2 receptor antagonists: part I. Pharmacological hybrids with pheniramine- and roxatidine-like substructures

By Schulze F.R.   Buschauer A.   Schunack W.  

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 3, 1998-07 ,pp. : 177-186

Elsevier

Access to resources Recommend Favorite

Combined histamine H 1 /H 2 receptor antagonists: Part II. - Pharmacological hybrids with pheniramine- and tiotidine-like substructures

By Wolf C.   Schulze F.R.   Buschauer A.   Schunack W.  

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 3, 1998-07 ,pp. : 187-196

Elsevier

Access to resources Recommend Favorite

Treatment with Ebastine Changes Expression of Histamine H and H Receptor mRNA on Peripheral Blood Mononuclear Cells

By Zak-Nejmark T.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 25-30

Adis International

Access to resources Recommend Favorite

Stable expression of the recombinant human VIP 1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties

By Gaudin P.   Couvineau A.   Maoret J.-J.   Rouyer-Fessard C.   Laburthe M.  

European Journal of Pharmacology, Vol. 302, Iss. 1, 1996-04 ,pp. : 207-214

Elsevier

Access to resources Recommend Favorite